DK1117689T3 - Knoglemorfogenese-proteinantagonist baseret på det modne protein - Google Patents

Knoglemorfogenese-proteinantagonist baseret på det modne protein

Info

Publication number
DK1117689T3
DK1117689T3 DK99944750.1T DK99944750T DK1117689T3 DK 1117689 T3 DK1117689 T3 DK 1117689T3 DK 99944750 T DK99944750 T DK 99944750T DK 1117689 T3 DK1117689 T3 DK 1117689T3
Authority
DK
Denmark
Prior art keywords
residue
amino acid
residues
protein
mature
Prior art date
Application number
DK99944750.1T
Other languages
English (en)
Inventor
Mieko Katsuura
Michio Kimura
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh
Application granted granted Critical
Publication of DK1117689T3 publication Critical patent/DK1117689T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK99944750.1T 1998-10-09 1999-10-04 Knoglemorfogenese-proteinantagonist baseret på det modne protein DK1117689T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10288103A JP2000119192A (ja) 1998-10-09 1998-10-09 骨誘導因子アンタゴニスト活性を有する成熟型蛋白質
PCT/IB1999/001621 WO2000021998A1 (en) 1998-10-09 1999-10-04 Bone morphogenetic protein antagonist based on the mature protein

Publications (1)

Publication Number Publication Date
DK1117689T3 true DK1117689T3 (da) 2012-07-09

Family

ID=17725844

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944750.1T DK1117689T3 (da) 1998-10-09 1999-10-04 Knoglemorfogenese-proteinantagonist baseret på det modne protein

Country Status (11)

Country Link
US (1) US7132397B1 (da)
EP (1) EP1117689B1 (da)
JP (1) JP2000119192A (da)
AT (1) ATE551359T1 (da)
AU (1) AU5756099A (da)
CA (1) CA2345201C (da)
CY (1) CY1112822T1 (da)
DK (1) DK1117689T3 (da)
ES (1) ES2382992T3 (da)
PT (1) PT1117689E (da)
WO (1) WO2000021998A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
CA2363965C (en) 1991-03-11 2010-05-18 Curis, Inc. Protein-induced morphogenesis
US7811793B2 (en) 1996-12-25 2010-10-12 Biopharma Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Process for preparing purified active monomer of bone-derived factor
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
US8257438B2 (en) * 2005-04-12 2012-09-04 Warsaw Orthopedic, Inc. Methods and devices for preserving motion in an articulating prosthetic disc
ES2382464T3 (es) * 2005-11-18 2012-06-08 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Mutantes de factor del crecimiento de actividad elevada
US8075562B2 (en) * 2007-06-25 2011-12-13 Wisconsin Alumni Research Foundation Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
EP2602264A1 (en) 2011-12-05 2013-06-12 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH GDF-5 mutant for inducing cartilage formation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691349A3 (en) 1994-07-04 1997-09-10 Hoechst Japan Dimeric bone morphogenetic proteins and their fragments and analogues and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
AU5756099A (en) 2000-05-01
EP1117689A1 (en) 2001-07-25
US7132397B1 (en) 2006-11-07
CY1112822T1 (el) 2016-02-10
JP2000119192A (ja) 2000-04-25
PT1117689E (pt) 2012-06-01
CA2345201A1 (en) 2000-04-20
ES2382992T3 (es) 2012-06-15
EP1117689B1 (en) 2012-03-28
WO2000021998A1 (en) 2000-04-20
CA2345201C (en) 2011-05-24
ATE551359T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
CY1112822T1 (el) Ανταγωνιστης μορφογενετικων πρωτεϊνων οστων με βαση την ωριμη πρωτεϊνη
ATE219685T1 (de) Zusammensetzungen enthaltend eine kombination von knochenmorphogenetischem protein und parathyroid- ähnlichem peptid
ATE300613T1 (de) Menschliche, für zyklische nukleotide spezifische phosphodiesterase
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
ES2130177T3 (es) Tratamiento de poblaciones de celulas.
DE69736428D1 (de) RET-LIGAND 3 (RetL3), UM NEURALES UND RENALES WACHSTUM ZU STIMULIEREN
BR9609006A (pt) Peptìdeo, composição farmacêutica, e, processo para tratamento dse paciente.
DK0506574T3 (da) Protein med aktivitet af cytokintype, rekombinant-DNA, der koder for dette protein, celler og transformerede mikroorganismer
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
ATE403726T1 (de) Cytokin-proteinfamilie
EP1132402A4 (en) PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTIVE ACTIVITY
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE512217T1 (de) 5-substituerte hydantoin racemase, dafür kodierende dna, und verfahren zur herstellung optisch aktiver aminosäure
DE69433902D1 (de) Neuartige tyrosinkinase
GB0210783D0 (en) Anti-microbial polypeptides
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
EP1362915A4 (en) FROM NOMURAEA RILEYI COMMUNICATING ECDYSTEROID-22-OXIDASE AND SYSTEM FOR MOISTURIZING HORMONE INACTIVATION THEREWITH
PL355852A1 (en) Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients
DE59710091D1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
GB2361923A (en) Novel protein
WO2003022300A1 (en) Preventives/remedies for bone/joint diseases
WO1997037028A3 (de) Ribose-5-phosphat isomerase (d-ribose-5-phosphat ketol isomerase, ec 5.3.1.6)
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE278784T1 (de) Polypeptide
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same